MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
2.730
-0.190 (-6.51%)
At close: Mar 24, 2026, 4:00 PM EDT
2.800
+0.070 (2.56%)
After-hours: Mar 24, 2026, 7:52 PM EDT
MacroGenics Market Cap
MacroGenics has a market cap or net worth of $173.51 million as of March 24, 2026. Its market cap has increased by 21.76% in one year.
Market Cap
173.51M
Enterprise Value
20.36M
1-Year Change
21.76%
Ranking
Category
Stock Price
$2.73
Market Cap Chart
Since October 10, 2013, MacroGenics's market cap has decreased from $600.30M to $173.51M, a decrease of -71.10%. That is a compound annual growth rate of -9.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 185.60M | 82.32% |
| Dec 31, 2025 | 101.80M | -50.10% |
| Dec 31, 2024 | 204.00M | -65.81% |
| Dec 29, 2023 | 596.70M | 44.65% |
| Dec 30, 2022 | 412.50M | -58.05% |
| Dec 31, 2021 | 983.20M | -23.47% |
| Dec 31, 2020 | 1.28B | 141.41% |
| Dec 31, 2019 | 532.20M | -0.84% |
| Dec 31, 2018 | 536.70M | -23.28% |
| Dec 29, 2017 | 699.60M | -1.74% |
| Dec 30, 2016 | 712.00M | -33.00% |
| Dec 31, 2015 | 1.06B | 9.02% |
| Dec 31, 2014 | 974.80M | 42.04% |
| Dec 31, 2013 | 686.30M | 14.33% |
| Oct 10, 2013 | 600.30M | - |
View and export this data all the way back to 2013. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 182.46M |
| Zentalis Pharmaceuticals | 178.46M |
| Caribou Biosciences | 175.88M |
| Connect Biopharma Holdings | 174.98M |
| NeOnc Technologies Holdings | 170.87M |
| Adagene | 170.14M |
| Whitehawk Therapeutics | 169.44M |
| Fennec Pharmaceuticals | 169.26M |